Genizon and Institute for Clinical Molecular Biology Replicates Disease Gene Discoveries in Crohn's Disease
Results Confirm the Power of Genizon's Platform and the Quebec Founder Population for Disease Gene Discovery
A selection of narrowly defined candidate regions, previously announced by Genizon from a whole genome association study on Crohn's disease, was fine mapped using samples from a German population, collected by a group led by Professor Stefan Schreiber, Director of the Institute for Clinical Molecular Biology. These regions have led to a comprehensive GeneMap for Crohn's disease, consisting of multiple interacting genes, biochemical pathways and prospective targets for therapeutic intervention.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.